HSR21-067: What Patient-Reported Outcomes Are Being Used in Non-small Cell Lung Cancer? A Targeted Literature Review of Randomized Clinical Trials and Regulatory Labeling

Authors: Kajal Patel PhD 1 , Soham Shukla PharmD 1 , Jennifer Hanlon MPH 2 , Kelly Bell PharmD 1 , Laurie Eliason MPH 2 and Cosmina Hogea PhD 3
View More View Less
  • 1 GlaxoSmithKine, Collegeville, PA
  • 2 GlaxoSmithKline, Waltham, MA
  • 3 GlaxoSmithKline, Philadelphia, PA
Volume/Issue:
Volume 19: Issue 3.5
Online Publication Date:
17 Mar 2021
DOI:
https://doi.org/10.6004/jnccn.2020.7726
Restricted access

All currencies in US Dollar

PayPal Logo

Corresponding Author: Kajal Patel, PhD
Copyright:
Copyright © 2021 by the National Comprehensive Cancer Network 2021
Page Numbers:
HSR21-067
Article Category:
Abstract
Print Publication Date:
20 Mar 2021
Online Publication Date:
17 Mar 2021
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 47 47 15
PDF Downloads 102 102 13
EPUB Downloads 0 0 0